Clinical Trial Update: Adequacy of Perioperative Cefazolin for Surgery Antibiotic Prophylaxis in Obese Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating perioperative cefazolin for surgical antibiotic prophylaxis in obese patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Ancef (cefazolin)
• CEFAZOLIN (cefazolin sodium)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Obesity | Phase 4 | Status: WITHDRAWN